Literature DB >> 3052961

Effects of long-term CAPD on carbohydrate and lipid metabolism.

N Lameire1, D Matthys, E Matthys, R Beheydt.   

Abstract

Long-term follow-up of CAPD patients indicates that these patients are at relatively low risk for developing de novo diabetes mellitus. Transperitoneal glucose absorption and the blood glucose and serum insulin response to the glucose load remain relatively unchanged with time. Alterations in lipid metabolism do occur; there is a tendency for the triglyceride levels to increase after 1 year and to maintain these high values with time. Total HDL cholesterol and its subfractions HDL2 and HDL3 remain unchanged and in the low normal range. Apoprotein A1 levels increase after 1 year and are maintained in the normal range.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3052961

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  Older Age, Higher Body Mass Index and Inflammation Increase the Risk for New-Onset Diabetes and Impaired Glucose Tolerance in Patients on Peritoneal Dialysis.

Authors:  Jie Dong; Zhi-Kai Yang; Yuan Chen
Journal:  Perit Dial Int       Date:  2016-02-04       Impact factor: 1.756

2.  Metabolic syndrome in peritoneal dialysis patients.

Authors:  Philip Kam-Tao Li; Bonnie Ching-Ha Kwan; Cheuk Chun Szeto; Gary Tin-Choi Ko
Journal:  NDT Plus       Date:  2008-06-27

3.  Glucose challenge test (50-g GCT) in detection of glucose metabolism disorders in peritoneal dialysis patients: preliminary study.

Authors:  Katarzyna Madziarska; Slawomir Zmonarski; Jozef Penar; Magdalena Krajewska; Oktawia Mazanowska; Hanna Augustyniak-Bartosik; Tomasz Gołebiowski; Renata Klak; Waclaw Weyde; Marian Klinger
Journal:  Int Urol Nephrol       Date:  2014-12-25       Impact factor: 2.370

Review 4.  New-Onset Diabetes Mellitus in Peritoneal Dialysis and Hemodialysis Patients: Frequency, Risk Factors, and Prognosis-A Review.

Authors:  Rajashri Yarragudi; Alois Gessl; Andreas Vychytil
Journal:  Ther Apher Dial       Date:  2019-04-23       Impact factor: 1.762

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.